Abstract | BACKGROUND: Direct-acting antiviral (DAA) agents can successfully treat chronic hepatitis C virus (HCV) infection. However, the ex vivo HCV-specific T-cell function following viral clearance remains unknown. METHODS: We investigated functional alterations and phenotypic changes in ex vivo HCV-specific CD8+ T cells with a longitudinal analysis of 41 patients with chronic HCV infection who were undergoing DAA treatment. RESULTS: A patient subset exhibited a significantly increased T-cell response (mainly CD8+ T cells) at week 4 of treatment. However, this increased T-cell response diminished in later weeks. Relative to pretreatment levels, the ex vivo HCV-specific CD8+ T-cell frequency decreased at 12 weeks after the end of treatment, along with a decreased antigen-experienced CD8+ T-cell population. DAA treatment increased the proliferative capacity of HCV-specific CD8+ T cells, but this change was not correlated with ex vivo function. Patients experiencing viral breakthrough or relapse exhibited defective restoration of T-cell function. CONCLUSION: Our present results indicated that DAA-mediated viral clearance only transiently restored ex vivo T-cell function, suggesting a need to enhance T-cell function in DAA-treated patients.
|
Authors | Ji Won Han, Pil Soo Sung, Kyung Hwan Kim, Seon-Hui Hong, Eui-Cheol Shin, Myeong Jun Song, Su-Hyung Park |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 220
Issue 8
Pg. 1290-1301
(09 13 2019)
ISSN: 1537-6613 [Electronic] United States |
PMID | 31152667
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected]. |
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents
(pharmacology, therapeutic use)
- CD8-Positive T-Lymphocytes
(drug effects, immunology)
- Cell Proliferation
(drug effects)
- Female
- Hepacivirus
(drug effects, immunology, isolation & purification)
- Hepatitis C, Chronic
(drug therapy, immunology, virology)
- Humans
- Male
- Middle Aged
- Prospective Studies
- Recurrence
- Sustained Virologic Response
- Time Factors
|